Dr. Quaid Saeed, CEO of IHRA, chaired a consultative session at the Islamabad Healthcare Regulatory Authority (IHRA) alongside other departments.
The meeting aimed Agenda for meeting:
Discussion on IHRA’s draft of regenerative medicine MSDS to review and comment on the draft.
During last month Islamabad Healthcare Regulatory Authority (IHRA) has conducted 58 inspections in different sectors and areas of Islamabad. Due to grave irregularities found in the functioning of certain healthcare establishments the Authority sealed 02 Healthcare Establishments (HCEs) in different areas of ICT. Similarly, IHRA suspended the services of 02 Healthcare Establishments (HCEs) over different medical noncompliance, 29 Healthcare Establishments were served notices for minor non-compliances. On the other hand, 03 Healthcare Establishments (HCEs) were recommended for registration.
IHRA has organized a one-day workshop/training session on “Safety of High Alert Medicines” based on guidelines notified by DRAP-Pakistan, for the healthcare providers working in different public & private hospitals, in collaboration with Shifa International Hospital and Pakistan Society of Health-System Pharmacists, PSHP.
